Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)

✍ Scribed by Knopp, R. H.; d'Emden, M.; Smilde, J. G.; Pocock, S. J.

• Book ID: 119976368
• Publisher: American Diabetes Association
• Year: 2006
• Tongue: English
• Weight: 274 KB
• Volume: 29
• Category: Article
• ISSN: 0149-5992
• DOI: 10.2337/dc05-2415